Skip to content
Scalper1
Trading Stocks Since 1985
  • HOME
  • NYSE
  • NASDAQ
  • CNN Money
  • Yahoo Finance
  • Stock Twits

J&J and Astellas Collaborate – Analyst Blog

By Scalper1 | October 3, 2012
0 Comment

Johnson & Johnson ‘s (JNJ) Janssen Biotech, Inc. recently entered into a licensing agreement with Astellas Pharma Inc

See the original post:
J&J and Astellas Collaborate – Analyst Blog

Related posts:

  1. Abbott-Astellas Collaborate – Analyst Blog
  2. Microsoft, NBC Sports Collaborate – Analyst Blog
  3. Isis Pharma, AstraZeneca Ink Deal – Analyst Blog
  4. Nokia to Collaborate with Verizon – Analyst Blog
Category: nasdaq stocks Tags: business, investing, nasdaq, research in motion, rimm, stocks
Post navigation
← VeriSign Sees More Domain Names – Analyst Blog NuStar Closes Asphalt Biz Stake Sale – Analyst Blog →

Recent Posts

  • Why Agarwood Oud Oil Has Become More Precious Than Gold
  • New Agarwood Plantation Launched in Manipur India
  • India’s Agarwood Trees Just Step Away From Extinction
  • Musang King Challenged by New Royal Durian
  • Organic vs. Natural – What You Need To Know!

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    custom footer text left
    custom footer text right
    Iconic One Theme | Powered by Wordpress